Developments in the management of mycetomas

Clinical and Experimental Dermatology

Volumn 34, Issue 1, 2009, Pages 1-7

  Ameen, M ^a   Arenas, R ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; FLUCONAZOLE; GENTAMICIN; GRISEOFULVIN; IMIPENEM; ITRACONAZOLE; KETOCONAZOLE; LINEZOLID; OXAZOLIDINONE DERIVATIVE; POSACONAZOLE; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; TERBINAFINE; TETRACYCLINE; VORICONAZOLE;

ACTINOMYCETOMA; ASPIRATION BIOPSY; BLOOD TESTIS BARRIER; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; EUMYCETOMA; HUMAN; MULTIPLE CYCLE TREATMENT; MYCETOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIAL TYPING TECHNIQUES; HUMANS; MADURELLA; MYCETOMA; MYCOLOGICAL TYPING TECHNIQUES; TROPICAL CLIMATE;

EID: 57349134628     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03028.x     Document Type: Review

References (36)

1. Ahmed AO, Mukhtar MM, Kool-Sijmons M et al. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for the identification of Madurella mycetomatis. J Clin Microbiol 1999 37 : 3175 8.
2. Desnos-Ollivier M, Bretagne S, Dromer F et al. Molecular identification of black-grain mycetoma agents. J Clin Microbiol 2006 44 : 3517 23.
3. Van de Sande WW, Janse DJ, Hira V et al. Translationally controlled tumour protein from Madurella mycetomatis, a marker for tumorous mycetoma progression. J Immunol 2006 177 : 1997 2005.
4. Van de Sande WW, Fahal A, Verbrugh H, van Belkum A. Polymorphisms in genes involved in innate immunity predispose towards mycetoma susceptibility. J Immunol 2007 179 : 3065 74.
5. Borman AM, Linton CJ, Miles SJ, Johnson EM. Molecular identification of pathogenic fungi. J Antimicrob Chemother 2008 61 (Suppl. 1 7 12.
6. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol 2005 53 : 931 51.
7. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Mycetoma. Dermatol Clin 2007 25 : 195 202.
8. Mariat F, Destombes P, Segretain G. The mycetomas: clinical features, pathology, etiology and epidemiology. Contrib Microbiol Immunol 1977 4 : 1 39.
9. Lopez-Martinez R, Mendez-Tovar JL, Lavalle P et al. Epidemiology of mycetoma in Mexico: study of 2,105 cases (in Spanish). Gac Med Mex 1992 128 : 477 81.
10. McGinnis MR, Padhye AA. Fungi causing eumycotic mycetoma. In : Manual of Clinical Microbiology (Murray PR, Baron EJ, Jorgensen JH, eds 7th edn. Washington : ASM Press, 2003 : 1848 56.
11. Ahmed AO, Van Leeuwen W, Fahal A et al. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 2004 4 : 566 74.
12. EL Hag IA, Fahal AH, Khalil EAG. Fine needle aspiration cytology of mycetoma. Acta Cytol 1996 40 : 461 4.
13. Salinas-Carmona MC, Welsh O, Casillas SM. Enzyme-linked immunosorbent assay for serological diagnosis of Nocardia brasiliensis and clinical correlation with mycetoma infections. J Clin Microbiol 1993 31 : 2901 6.
14. Bonifaz A, Gonzalez-Silva A, Albrandt-Salmeron A et al. Utility of helical computed tomography to evaluate the invasion of actinomycetoma: a report of 21 cases. Br J Dermatol 2008 158 : 698 704.
15. Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg 2004 98 : 3 11.
16. Mahgoub ES. Treatment of actinomycetoma with sulphamethoxazole plus trimethoprim. Am J Trop Med Hyg 1972 21 : 332 5.
17. Dieng MT, Niang SO, Diop B, Ndiaye B. Actinomycetomas in Senegal. Study of 90 cases (in French). Bull Soc Pathol Exot Filiales 2005 98 : 18 20.
18. Mahgoub ES. Medical management of mycetoma. Bull World Health Organ 1976 54 : 3003 311.
19. Welsh O, Sauceda E, Gonzalez J, Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol 1987 17 : 443 8.
20. Bonifaz A, Flores P, Saul A et al. Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate. Br J Dermatol 2007 156 : 308 11.
21. Moylett EH, Pacheco SE, Brown-Elliott BA et al. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis 2003 36 : 313 18.
22. Fuentes A, Arenas R, Reyes M et al. Actinomycetoma and Nocardia sp. Report of five cases treated with imipenem or imipenem plus amikacin (in Spanish). Gac Med Mex 2006 142 : 247 52.
23. Vera-Cabrera L, Gomez-Flores A, Escalante-Fuentes WG, Welsh O. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemother 2001 45 : 3629 30.
24. Welsh O, Salinas MC, Rodriguez MA. Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol 1995 6 : 47 71.
25. N'Diaye B, Dieng MT, Perez A et al. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 2006 45 : 154 7.
26. Mahgoub ES, Gumaa SA. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg 1984 78 : 376 9.
27. Venugopal PV, Venugopal TV. Treatment of eumycetoma with ketoconazole. Australas J Dermatol 1993 34 : 27 9.
28. Lacroix C, De Kerviler E, Morel P et al. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol 2005 152 : 1067 8.
29. Negroni R, Tobon A, Bustamante B et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2005 47 : 339 46.
30. Porte L, Khatibi S, Hajj LE et al. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans R Soc Trop Med Hyg 2006 100 : 891 4.
31. Loulergue P, Hot A, Dannaoui E et al. Successful treatment of black-grain mycetoma with voriconazole. Am J Trop Med Hyg 2006 75 : 1106 7.
32. Ahmed AO, van Vianen W, ten Kate MT et al. A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol Med Microbiol 2003 37 : 29 36.
33. Ramam M, Bhat R, Garg T et al. A modified two-step treatment for actinomycetoma. Indian J Dermatol Venereol Leprol 2007 73 : 235 9.
34. Joshi R. Treatment of actinomycetoma with combination of rifampicin and co-trimoxazole. Indian J Dermatol Venereol Leprol 2008 74 : 166 8.
35. Smith EL, Kutbi S. Improvement of eumycetoma with itraconazole. J Am Acad Dermatol 1997 34 : 279 80.
36. Castro LG, Piquero-Casals J. Clinical and mycologic findings and therapeutic outcome of 27 mycetoma patients from São Paulo, Brazil. Int J Dermatol 2008 47 : 160 3.